Patient stratification

Patient stratification

ALCEDIAG biomarkers allow identifying a group of patients with shared “biological” characteristics. This stratification enables medical professionals to select the optimal management for the patient and achieve the best possible outcome. 

In this context, the use of biomarkers can help identify patients that are more likely to respond favorably to a given therapy. Theses biomarkers are useful for pharmaceutical companies when selecting the group of patients who are the best clinical responders.

Need more informations?